Health and Pharmaceuticals

Deutsche, UBS and Morgan Stanley to advise on Estia IPO

Quadrant paid $90 million last October for a majority stake in Estia, which cares for over 1,000 seniors in Victoria.

Healthscope IPO priced at higher end, raises $2.26bn

Healthscope confirmed its IPO priced at $2.10 per share following a well-covered institutional book build.

Malaysian fund invests heavily in Healthscope

Employees Provident Fund emerges as one of the largest investors in the Healthscope IPO.

Cash injection for herpes vaccine

Admedus injects $6m into joint venture firm Admedus Vaccines, which is chaired by Ian Frazer.

Healthscope raises $2.25bn in IPO

The biggest IPO in four years prices at $2.10 a share, owners to keep 38%.

Healthscope set to price near top of range

The book build for the $2.6 billion IPO closes later on Thursday, and early indications are that demand is strong.

GlaxoSmithKline posts steep fall in Q2 profit

Weak respiratory drug sales, currency moves, bribery investigation hit drugmaker.

PE commitment to Healthscope is welcome

Carlyle and TPG will continue to hold a substantial stake in the hospitals operator after the IPO.

Biotech hopeful sets IPO plan

Orthocell will have a market value of around $33m after listing.

Healthscope opens institutional bids early

The $2.6 billion IPO – the biggest in four years – has tapped fund managers to start placing bids for stock early.

Healthscope trims hospital ahead of IPO

Australian Unity is buying a hospital from Healthscope as the giant prepares for its $2.6bn IPO.

AbbVie seals $54 billion Shire takeover

Purchase forms world's largest-ever 'inversion' deal.

Novartis, Google to develop 'smart' contact lens

Swiss drugmaker to work with Google in building lenses that would help diabetics to track their blood glucose levels or restore the eye's ability to focus.

J+J profit lifts in Q2

New hepatitis C drug boosts healthcare group's result.

Healthscope IPO backed by over $1bn retail demand

Strong retail interest will be priced at same level as in institutional book build.

Healthscope IPO backed by over $1bn retail demand

Strong retail interest will be priced at same level as in institutional book build.

DoseMe adds a measure of medical safety

Brisbane-based technology start-up is on the cusp of cracking the global market for safer medical prescriptions.

US giant AbbVie close to $US53bn 'inversion deal'

Purchase of Dublin healthcare group would enable lower corporate tax burden.

Push for employee ownership in Australia Hearing sale

Some staff have been calling for employee ownership of the business instead of a sale to a multi-national.

Govt calls for co-managers to sell Medibank IPO

Precise timing and structure of the offering still to be determined.